Work

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

Year: 1998

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1998.16.7.2468

Authors: D J Kwiatkowski, D H Harpole, J Godleski, J E Herndon, D B Shieh, W Richards, R Blanco, H J Xu, G M Strauss, D J Sugarbaker

Institutions: Brigham and Women's Hospital, Harvard University

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: World Health Organization, National Institutes of Health, National Cancer Institute

Awards: G2718401887, TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE, G5686872090, PROGNOSTIC FACTOR ANALYSIS IN STAGE I NSCLC

OpenAlex ID: W2148725505

FWCI: 13.74

Cites: 25

Cited by: 178

Related to: 10